Get Real Time Here
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biolase Stock (NASDAQ:BIOL), Quotes and News Summary
Biolase Stock (NASDAQ: BIOL) stock price, news, charts, stock research, profile.
| Open1.820 | Close1.860 |
| Vol / Avg.167.604K / 313.932K | Mkt Cap1.910M |
| Day Range1.700 - 1.910 | 52 Wk Range1.560 - 268.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.850 | (EXPECTED) 2023-11-09 | |||||
| REV | 13.960M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -5.330 | -4.240 | 1.0900 | ||||
| REV | 15.360M | 14.286M | -1.074M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Lake Street | Frank Takkinen | Maintains | BuyBuy | Lowers | 1.50 | 0.40 |
| 2023-03-29 | Maxim Group | Anthony Vendetti | Maintains | Buy | Lowers | 5.00 | 1.00 |
| 2023-03-29 | Benchmark | Bruce Jackson | Reiterates | Speculative Buy | Maintains | - | 2.00 |
| 2023-01-20 | Lake Street | Frank Takkinen | Assumes | Buy | Announces | - | 1.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIOL | Biolase | 1.67% | 1.9M |
| VTAK | Catheter Precision | -1.27% | 2.9M |
| NXL | Nexalin Technology | -12.94% | 3.1M |
| MOTS | Motus GI Hldgs | 0% | 2.7M |
| TIVC | Tivic Health Systems | -3.35% | 2.5M |
How do I buy Biolase (BIOL) stock?
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Who are Biolase's (BIOL) competitors?
Other companies in Biolase’s space includes: Catheter Precision (AMEX:VTAK), Nexalin Technology (NASDAQ:NXL), Motus GI Hldgs (NASDAQ:MOTS), Tivic Health Systems (NASDAQ:TIVC) and Reshape Lifesciences (NASDAQ:RSLS).
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months (a possible -78.14% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Biolase (BIOL)?
The stock price for Biolase (NASDAQ: BIOL) is $1.83 last updated Today at September 29, 2023 at 11:26 PM UTC.
Does Biolase (BIOL) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2013 to stockholders of record on June 12, 2013.
When is Biolase (NASDAQ:BIOL) reporting earnings?
Biolase’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Biolase (BIOL) going to split?
There is no upcoming split for Biolase.
What sector and industry does Biolase (BIOL) operate in?
Biolase is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.